Fibromyalgia Impact Questionnaire (FIQ): Difference between revisions
Kim Jackson (talk | contribs) mNo edit summary |
Kim Jackson (talk | contribs) No edit summary |
||
| Line 23: | Line 23: | ||
[[Image:FIQ_2.png|center]] | [[Image:FIQ_2.png|center]] | ||
== | == Resources == | ||
[https://fiqrinfo.ipage.com/ Link to the Fibromyalgia Impact Questionnaire] | |||
[https://fiqrinfo.ipage.com/Licensing.htm Link to Fibromyalgia Impact Questionnaire Licensing] | |||
== Evidence == | == Evidence == | ||
| Line 32: | Line 33: | ||
== References == | == References == | ||
<references /> | <references /> | ||
[[Category:Outcome Measures]] | [[Category:Outcome Measures]] | ||
Latest revision as of 14:26, 27 March 2023
Original Editor - Ajay Upadhyay
Top Contributors - Ajay Upadhyay, Kim Jackson, WikiSysop and George Prudden
Objective[edit | edit source]
The FIQ is an assessment and evaluation instrument developed to measure fibromyalgia (FM) patient status, progress and outcomes. [1]
Intended Population[edit | edit source]
It has been designed to measure the components of health status that are believed to be most affected by FM.
Method of Use[edit | edit source]
The FIQ is a self administered instrument that takes approximately 5 minutes to complete. The directions are simple and the scoring is self-explanatory.
The FIQ is composed of 10 items. The first item contains 11 questions related to physical functioning – each question is rated on a 4 point Likert type scale. Items 2 and 3 ask the patient to mark the number of days they felt well and the number of days they were unable to work (including housework) because of fibromyalgia symptoms. Items 4 through 10 are horizontal linear scales marked in 10 increments on which the patient rates work difficulty, pain, fatigue, morning tiredness, stiffness, anxiety and depression.
Resources[edit | edit source]
Link to the Fibromyalgia Impact Questionnaire
Link to Fibromyalgia Impact Questionnaire Licensing
Evidence[edit | edit source]
This initial assessment indicates that the FIQ has sufficient evidence of reliability and validity to warrant further testing in both research and clinical situations.
References[edit | edit source]
- ↑ Burckhardt CS1, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: development and validation.J Rheumatol. 1991 May;18(5):728-33.
